Sterling Investment Advisors (Pennsylvania)’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.8K | Hold |
23,416
| – | – | 0.01% | 182 |
|
|
2025
Q1 | $35.1K | Sell |
23,416
-558
| -2% | -$837 | 0.01% | 174 |
|
|
2024
Q4 | $121K | Sell |
23,974
-10,500
| -30% | -$52.8K | 0.03% | 159 |
|
|
2024
Q3 | $278K | Buy |
34,474
+1,000
| +3% | +$8.06K | 0.07% | 127 |
|
|
2024
Q2 | $193K | Sell |
33,474
-900
| -3% | -$5.18K | 0.05% | 136 |
|
|
2024
Q1 | $409K | Hold |
34,374
| – | – | 0.12% | 108 |
|
|
2023
Q4 | $643K | Hold |
34,374
| – | – | 0.2% | 89 |
|
|
2023
Q3 | $326K | Hold |
34,374
| – | – | 0.11% | 109 |
|
|
2023
Q2 | $491K | Buy |
34,374
+1,000
| +3% | +$14.3K | 0.16% | 96 |
|
|
2023
Q1 | $514K | Buy |
33,374
+900
| +3% | +$13.9K | 0.17% | 95 |
|
|
2022
Q4 | $436K | Hold |
32,474
| – | – | 0.16% | 105 |
|
|
2022
Q3 | $445K | Buy |
32,474
+5,500
| +20% | +$75.4K | 0.17% | 102 |
|
|
2022
Q2 | $306K | Buy |
26,974
+8,000
| +42% | +$90.8K | 0.11% | 111 |
|
|
2022
Q1 | $253K | Buy |
18,974
+4,500
| +31% | +$60K | 0.07% | 132 |
|
|
2021
Q4 | $254K | Hold |
14,474
| – | – | 0.07% | 135 |
|
|
2021
Q3 | $460K | Sell |
14,474
-6,100
| -30% | -$194K | 0.14% | 112 |
|
|
2021
Q2 | $1.76M | Sell |
20,574
-11,104
| -35% | -$950K | 0.52% | 61 |
|
|
2021
Q1 | $884K | Sell |
31,678
-18,910
| -37% | -$528K | 0.29% | 84 |
|
|
2020
Q4 | $381K | Sell |
50,588
-450
| -0.9% | -$3.39K | 0.13% | 104 |
|
|
2020
Q3 | $245K | Buy |
+51,038
| New | +$245K | 0.09% | 114 |
|